Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Imipenem MeSH Descriptor Data 2026


MeSH Heading
Imipenem
Tree Number(s)
D02.065.589.099.124.300.500
D03.633.100.300.124.300.500
Unique ID
D015378
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D015378
Scope Note
Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.
Entry Term(s)
Imipemide
Imipenem Anhydrous
Imipenem, Anhydrous
MK-0787
MK0787
N-Formimidoylthienamycin
Pharm Action
Anti-Bacterial Agents
Registry Numbers
71OTZ9ZE0A
Q20IM7HE75
0
Related Numbers
74431-23-5
Q20IM7HE75
CAS Type 1 Name
1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((2-((iminomethyl)amino)ethyl)thio)-7-oxo-, (5R-(5alpha,6alpha(R*)))-
NLM Classification #
QV 350
Previous Indexing
Antibiotics (1980-1982)
Thienamycins (1983-1988)
Public MeSH Note
89
History Note
89
Date Introduced
1989/01/01
Last Updated
2016/05/31
Imipenem Preferred
Imipenem, Anhydrous Narrower
MK-0787 Narrower
page delivered in 0.127s